Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.2147/jbm.s190327 ↗
- Volume · Issue · Pages
- Volume 10 · — · 265-278
- Publisher
- Dove Medical Press Ltd.
- Article URL
- https://doi.org/10.2147/jbm.s190327 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Aug 2019
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Aug 2019 | OpenAlex |
Keywords (as given): autoimmune hemolytic anemia; allogeneic hematopoietic stem cell transplantation; refractory disease; post-transplant complications; graft-versus-host disease; cytomegalovirus reactivation; alemtuzumab; risk factors; corticosteroids; intravenous immunoglobulin; splenectomy; rituximab; cyclophosphamide; plasma exchange; rapamycin; bortezomib; abatacept; daratumumab; complement inhibitors
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Journal of Blood Medicine
- Publication date used
- 01 Aug 2019 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.